Abstract
To evaluate the efficacy of dynamic susceptibility-contrast magnetic resonance (MR) imaging for diagnosis of intraaxial brain tumors. Ten patients with such tumors (two hemangioblastomas, five low-grade astrocytomas, and three glioblastomas) underwent examination at 1.5 T. After bolus injection of 0.15 mmol/kg gadopentetate dimeglumine, gradient-echo MR images were obtained every 3.6 seconds for 90 seconds. Region-of-interest analyses were performed in all tumors. The greatest loss in signal intensity during the first pass of the contrast agent was seen in hemangioblastomas; low-grade astrocytomas had the least loss. The differences in integration of change in the T2* relaxation rate were significant among the three types of tumor (hemangioblastomas vs low-grade astrocytomas, P < .001; hemangioblastomas vs glioblastomas, P < .005; and glioblastomas vs low-grade astrocytomas, P < .02) and indicated differences in vascularity. Dynamic susceptibility-contrast MR imaging can provide useful hemodynamic information about intraaxial brain tumors that is not provided by standard MR imaging and therefore contributes to the differential diagnosis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
